BioCentury
ARTICLE | Emerging Company Profile

Arch-backed Neumora: using data tools for precision neuroscience

By Paul Bonanos, Associate Editor
October 7, 2021 10:33 AM GMT

Deep-pocketed Arch, partner Amgen back Neumora’s eight-program pipeline in neuroscience

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Arch Venture Partners